Chao Wang | Gene Regulation Epigenetics | Research Excellence Award

Dr. Chao Wang | Gene Regulation Epigenetics | Research Excellence Award

Hangzhou First People’s Hospital | China

Dr. Chao Wang is a dedicated surgeon specializing in hepato-pancreato-biliary surgery and liver transplantation at The Affiliated Hangzhou First People’s Hospital, Zhejiang University. His expertise encompasses liver transplantation, hepatobiliary, and pancreatic surgery, with a strong focus on translational research integrating genetics and clinical outcomes. Dr. Wang has contributed extensively to understanding the role of donor gene polymorphisms, one-carbon metabolism, and molecular regulatory networks in post-transplant complications, hepatocellular carcinoma recurrence, and liver fibrosis. His publications span high-impact journals, exploring predictive models for transplant outcomes, immunosuppressive regimens, and novel molecular mechanisms such as the MAGI2-AS3/miRNA-374-5p/FOXO1 axis in HBV-related HCC. As a principal investigator and collaborator in multiple national and provincial research projects, he combines clinical practice with rigorous scientific investigation. Dr. Wang’s work advances personalized medicine in liver transplantation, providing valuable insights into genetic and molecular determinants of patient prognosis and post-operative management, reflecting a high h-index in his field.

Citation Metrics (Scopus)

6000
4000
2000
200
100
50
0

Citations
5,725

Documents
149

h-index
44

Citations

Documents

h-index

Featured Publications

Esmaa Bouhamida | Molecular and Cellular Biology | Cell Biology Research Award

Dr. Esmaa Bouhamida | Molecular and Cellular Biology | Cell Biology Research Award

Fondazione Ricerca Biomedica Avanzata (VIMM) | Italy

The candidate’s research centers on understanding how mitochondrial signaling, hypoxia-responsive pathways, and cell-cycle regulatory networks collectively influence cardiac regeneration and cardiovascular disease. Their work investigates how hypoxia-inducible factors, particularly HIF-1α, modulate mitochondrial function during ischemic injury, with the broader goal of identifying mechanisms that could restore or enhance the regenerative potential of adult cardiac tissue. Through advanced molecular and cellular approaches, their studies explore how metabolic rewiring, mitochondrial stress responses, and oxygen-sensing pathways govern cardiomyocyte survival, proliferation, and reprogramming.

Building on expertise in molecular biology, signal transduction, and genetics, the researcher has expanded their focus to include the interplay between mitochondrial homeostasis and protein-quality control mechanisms in muscle tissues. Their postdoctoral work examines signaling pathways that regulate proteostasis and their impact on muscle integrity under physiological and pathological conditions. This integrated approach bridges cardiac regeneration, mitochondrial dynamics, and muscle biology, enabling the identification of therapeutic targets relevant to heart failure, ischemia, and degenerative muscle disorders.

Their long-term vision is to develop interventions that combine mitochondrial modulation, gene therapy, and cellular reprogramming strategies to promote tissue repair and functional recovery in cardiovascular disease. Their contributions have been recognized through competitive scientific evaluations at international cardiovascular and stem-cell research forums.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

Bouhamida, E., Vadakke-Madathil, S., Mathiyalagan, P., Ranjan, A. K., Khan, A., Sherman, M. P., & others. (2025). Single nucleus transcriptomics supports a role for CCNA2-induced human adult cardiomyocyte cytokinesis. bioRxiv.

Bouhamida, E., Vadakke-Madathil, S., Mathiyalagan, P., Ranjan, A. K., Sherman, M. P., & others. (2025). Cyclin A2 induces cytokinesis in human adult cardiomyocytes and drives reprogramming in mice. npj Regenerative Medicine, 10(1), 47.